Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2014

Mar 4, 2014

30071_dirs_2014-03-04_6eef332e-aba7-4b9b-a891-876fc7e6d72b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2014-02-28

Reporting Person: Reiser Anne (President - ResMed Europe)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-02-28 ResMed Common Stock M 8000 $20.80 Acquired 68099.888 Direct
2014-02-28 ResMed Common Stock S 8000 $44.00 Disposed 60099.888 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-02-28 ResMed Common Stock Options $20.80 M 8000 Acquired 2015-02-26 ResMed Common Stock (8000) Direct

Footnotes

F1: Includes 144.873 shares purchased on October 31, 2013, through the company's Employee Stock Purchase Plan.